Csaba Peto, PhD
Associate Professor
Surgery
School of Medicine

Publications (5)

Top publication keywords:
NeoplasmsProtein Kinase InhibitorsMolecular Docking SimulationCoumestrolPhthalic AcidsHSP90 Heat-Shock ProteinsSmall Molecule LibrariesAntineoplastic AgentsCasein Kinase IIDrug DiscoveryCell Line, TumorNational Cancer Institute (U.S.)Crystallography, X-RayBiological ProductsAzabicyclo Compounds

• Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy.
  American journal of cancer research 2024 Brand NR, Yang YW, Ding V, Dutta H, Peto CJ, Lemjabbar-Alaoui H, Jablons DM
• AMXI-5001, a novel dual parp1/2 and microtubule polymerization inhibitor for the treatment of human cancers.
  American journal of cancer research 2020 Lemjabbar-Alaoui H, Peto CJ, Yang YW, Jablons DM
• Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
  BMC pharmacology & toxicology 2013 Liu S, Hsieh D, Yang YL, Xu Z, Peto C, Jablons DM, You L
• Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.
  Bioorganic & medicinal chemistry letters 2012 Bussenius J, Blazey CM, Aay N, Anand NK, Arcalas A, Baik T, Bowles OJ, Buhr CA, Costanzo S, Curtis JK, DeFina SC, Dubenko L, Heuer TS, Huang P, Jaeger C, Joshi A, Kennedy AR, Kim AI, Lara K, Lee J, Li…
• Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973).
  ACS medicinal chemistry letters 2012 Rice KD, Aay N, Anand NK, Blazey CM, Bowles OJ, Bussenius J, Costanzo S, Curtis JK, Defina SC, Dubenko L, Engst S, Joshi AA, Kennedy AR, Kim AI, Koltun ES, Lougheed JC, Manalo JC, Martini JF, Nuss JM,…